Second Phase-III-Induction Study (U-ACCOMPLISH) of Upadacitinib confirms improved clinical, endoscopic and histological Results in Patients with Ulcerative colitis

被引：0
|
作者：
不详
机构：
来源：
VISCERAL MEDICINE | 2021年 / 37卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [31] HISTOLOGICAL AND ENDOSCOPIC HEALING AFTER QBECO TREATMENT IN AN OPEN-LABEL PHASE 2 STUDY IN PATIENTS WITH ULCERATIVE COLITIS
    Pankovich, Jim
    Kalyan, Shirin
    Bazett, Mark
    Sham, Ho Pan
    Fedorak, Richard N.
    Marshall, John K.
    Bressler, Brian
    Sutcliffe, Simon
    Gunn, Hal
    GASTROENTEROLOGY, 2018, 154 (01) : S24 - S25
  • [32] Benefits of high versus low dose upadacitinib as maintenance treatment in ulcerative colitis patients who were responders to 8-week induction with upadacitinib: Results from the U-ACHIEVE phase 3 maintenance trial
    Feagan, Brian
    Parkes, Gareth
    Juillerat, Pascal
    Gecse, Krisztina
    Yao, Xuan
    Zhou, Wen
    Deng, Huiwen
    Ilo, Dapo
    Gonzalez, Yuri Sanchez
    Higgins, Peter D. R.
    SWISS MEDICAL WEEKLY, 2023, 153 : 2S - 2S
  • [33] Benefits of High versus Low Dose Upadacitinib as Maintenance Treatment in Ulcerative Colitis Patients Who Were Responders to 8-week Induction with Upadacitinib: Results From the U-ACHIEVE Phase 3 Maintenance Trial
    Feagan, Brian G.
    Parkes, Gareth
    Juillerat, Pascal
    Gecse, Krisztina
    Yao, Xuan
    Zhou, Wen
    Deng, Huiwen
    Ilo, Dapo
    Sanchez-Gonzalez, Yuri
    Higgins, Peter D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S496 - S496
  • [34] Histological remission is predictive of improved clinical outcomes in patients with ulcerative colitis: results from the TOUCHSTONE open-label extension
    Sandborn, W.
    Feagan, B.
    D'Haens, G.
    Levesque, B.
    Pai, R.
    Hanauer, S.
    Wolf, D.
    Vermeire, S.
    Ghosh, S.
    Li, C.
    Penenberg, D.
    Aranda, R.
    Olson, A.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S9 - S9
  • [35] Rapidity of Symptom Control with Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two Randomized Phase 3 Studies
    Loftus, Edward V.
    Takeuchi, Ken
    Gao, Xiang
    Panaccione, Remo
    Danese, Silvio
    Ilo, Dapo
    Finney-Hayward, Tricia
    Phillips, Charles
    Yao, Xuan
    Vermeire, Severine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S359 - S359
  • [36] Efficacy of Upadacitinib as an Induction Therapy in Severe and Refractory Ulcerative Colitis: Sub-Group Analysis of the Phase 2b Study U-ACHIEVE
    D'Haens, Geert R.
    Lindsay, James O.
    Loftus, Edward V., Jr.
    Zhou, Wen
    Cataldi, Fabio
    Xie, Wangang
    Pugatch, David
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S399 - S399
  • [37] Sustained remission in patients with moderate to severe ulcerative colitis: Results from the Phase III UNIFI maintenance study
    Van Assche, G.
    Targan, S.
    Baker, T.
    O'Brien, C.
    Zhang, H.
    Johanns, J.
    Szapary, P.
    Marano, C.
    Leong, R.
    Rowbotham, D.
    Hisamatsu, T.
    Danese, S.
    Sands, B.
    Peyrin-Biroulet, L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 154 - 155
  • [38] Correlation of histological assessment of mucosal healing with long-term clinical and patient-reported outcomes in patients with moderately to severely active ulcerative colitis treated with upadacitinib: results from the Phase 3 U-ACHIEVE maintenance trial
    Parkes, G.
    Ungaro, R.
    Danese, S.
    Abreu, M.
    Arenson, E.
    Zhou, W.
    Ilo, D.
    Laroux, F. S.
    Deng, H.
    Gonzalez, Y. Sanchez
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I476 - I477
  • [39] Correlation of histological assessment of mucosal healing with long-term clinical and patient-reported outcomes in patients with moderately to severely active ulcerative colitis treated with upadacitinib: results from the Phase 3 U-ACHIEVE maintenance trial
    Parkes, G.
    Ungaro, R.
    Danese, S.
    Abreu, M.
    Arenson, E.
    Zhou, W.
    Ilo, D.
    Laroux, F. S.
    Deng, H.
    Gonzalez, Y. Sanchez
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I476 - I477
  • [40] Correlation of histological assessment of mucosal healing with long-term clinical and patient-reported outcomes in patients with moderately to severely active ulcerative colitis treated with upadacitinib: Results from the Phase 3 U-ACHIEVE maintenance trial
    Parkes, G.
    Ungaro, R.
    Danese, S.
    Abreu, M.
    Arenson, E.
    Zhou, W.
    Ilo, D.
    Laroux, S.
    Deng, H.
    Gonzalez, Y. S.
    Peyrin-Biroulet, L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 157 - 157
12345